Physician profile
George Grunberger
NPI 1477558450
$930,769.46
in general payments reported to CMS, 2019-2025
67 companies · $139K in 2025
The $139K reported for 2025 was more than what 99% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $226K · 2020: $94K · 2021: $95K · 2022: $181K · 2023: $103K · 2024: $93K · 2025: $139K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $234K · Consulting Fee: $37K · Travel and Lodging: $28K · Food and Beverage: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Honoraria: $9,125 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $234,438.23 |
| Consulting Fee | $37,052.50 |
| Travel and Lodging | $28,198.05 |
| Food and Beverage | $15,461.70 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,618.75 |
| Honoraria | $9,124.60 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $452,232.57 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $113,077.49 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Abbott Laboratories | $76,867.91 | 2019-2025 | Freestyle Libre 3, Freestyle Libre, Freestyle Libre Pro |
| Sanofi-Aventis U.S. LLC | $69,787.63 | 2019-2025 | |
| Nevro Corp. | $45,320.97 | 2021-2024 | Senza |
| Lifescan, INC. | $21,101.84 | 2020-2023 | |
| Mannkind Corporation | $15,512.22 | 2019-2025 | Afrezza |
| Cequr Corporation | $14,552.26 | 2022-2025 | Cequr Simplicity |
| Vertex Pharmaceuticals Incorporated | $13,097.56 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $10,139.93 | 2019-2022 | |
| Senseonics, Incorporated | $10,136.00 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,906.93 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Xeris Pharmaceuticals, INC. | $9,634.62 | 2020-2025 | Gvoke Hypopen |
| Janssen Pharmaceuticals, INC | $9,160.74 | 2019-2022 | |
| Ipsen Bioscience INC. | $8,977.50 | 2023 |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Rcv Gmbh & Co Kg | $7,745.98 | 2019-2022 | |
| Tandem Diabetes Care, INC. | $5,883.84 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Amarin Pharma, INC. | $5,819.66 | 2019-2022 | |
| Dexcom, INC. | $4,726.74 | 2020-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $4,247.64 | 2021-2025 | Minimed 780g, Minimed 770g, Inpen Smart Insulin Delivery System |
| Lexicon Pharmaceuticals, INC. | $3,949.37 | 2019-2025 | Inpefa |
| Corcept Therapeutics | $3,530.90 | 2019-2025 | Korlym |
| Valeritas, INC. | $3,342.34 | 2019 | |
| Becton, Dickinson and Company | $3,088.12 | 2019-2022 | |
| Eli Lilly and Company | $2,625.00 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,504.74 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $1,341.98 | 2019-2020 | |
| Esperion Therapeutics, INC. | $355.73 | 2021-2025 | Nexletol |
| Amgen INC. | $350.51 | 2022-2025 | Evenity, Tepezza, Prolia |
| Radius Health, INC. | $251.93 | 2022-2025 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $233.09 | 2022-2025 | |
| Sequel Med Tech, LLC | $217.84 | 2025 | Twiist |
| Beta Bionics, INC. | $154.85 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Antares Pharma, INC. | $145.99 | 2021-2023 | Tlando, Xyosted, Nocdurna |
| Clarus Therapeutics INC. | $137.44 | 2021 | |
| Insulet Corporation | $120.38 | 2019-2024 | Omnipod |
| Medtronic Minimed, INC. | $115.11 | 2019-2020 | |
| Ascendis Pharma Endocrinology INC | $102.40 | 2023 | |
| Ascensia Diabetes Care US INC. | $91.30 | 2024-2025 | |
| Amneal Pharmaceuticals LLC | $88.34 | 2022-2024 | Unithroid |
| Recordati_rare_diseases_inc. | $81.94 | 2020-2024 | Isturisa, Signifor Lar |
| Ipsen Biopharmaceuticals, INC | $79.80 | 2020-2022 | |
| Embecta Corp. | $71.97 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Madrigal Pharmaceuticals | $70.43 | 2025 | Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $62.24 | 2021 | |
| Amryt Pharma Holdings Ltd | $57.93 | 2022 | |
| Amphastar Pharmaceuticals, INC. | $56.05 | 2024-2025 | |
| Vivus LLC | $55.87 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $48.97 | 2023 | Strensiq |
| Janssen Scientific Affairs, LLC | $48.63 | 2019 | |
| Abbvie INC. | $46.41 | 2020-2021 | |
| Ultragenyx Pharmaceutical INC. | $45.56 | 2023-2024 | Crysvita |
| Kyowa Kirin, INC. | $44.07 | 2025 | |
| Companion Medical, INC. | $43.34 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $37.48 | 2021 | |
| Horizon Therapeutics Plc | $33.96 | 2020-2022 | |
| Chiesi USA, INC. | $33.66 | 2024-2025 | Mycapssa |
| Averitas Pharma INC. | $28.14 | 2023 | Qutenza |
| Neurocrine Biosciences, INC. | $26.75 | 2024 | Crenessity |
| Novartis Pharmaceuticals Corporation | $22.50 | 2022 | |
| Alvogen INC | $22.20 | 2024 | Teriparatide |
| Eusa Pharma (US) LLC | $19.99 | 2022 | |
| Grt US Holding, INC. | $14.56 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.78 | 2021 | |
| Alfasigma USA, INC. | $13.21 | 2021 | |
| Eisai INC. | $12.63 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$13,711.34 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Grunberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.